Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (5.558)

61

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer : a multicenter, open-label, randomized, controlled, phase 3 trial

enthalten in: Signal transduction and targeted therapy | 2024

von Pan, Q. | Zhao, J. | Liu, L. | +27

62

KESTREL and KITE Phase 3 Studies : 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

enthalten in: American journal of ophthalmology | 2024

von Wykoff, C. | Garweg, J. | Regillo, C. | +12

63

Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study) : a French multicenter randomized phase III study

enthalten in: Journal of neurosurgery | 2024

von Picart, T. | Pallud, J. | Berthiller, J. | +33

64

Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension

enthalten in: Epilepsia open | 2024

von Nishida, T. | Lee, S. | Inoue, Y. | +5

65

Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density : A Secondary Analysis of a Phase 3 Randomized Controlled Trial

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Roy, S. | Malone, S. | Sun, Y. | +8

66

FDA Approval Summary : Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Woods, A. | Norsworthy, K. | Wang, X. | +9

67

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

68

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

69

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype : A Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Lorusso, D. | Raspagliesi, F. | Ronzulli, D. | +20

70

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy : A Phase 3 Randomized Clinical Trial in China

enthalten in: Diabetes | 2024

von Guo, L. | Pan, Q. | Cheng, Z. | +10